Illumina’s global headquarters in San Diego. REUTERS/Mike Blake Illumina said on Tuesday Chief Financial Officer Joydeep Goswami will leave the San Diego-based gene sequencing company and be succeeded by former Summit Therapeutics‘ executive Ankur Dhingra. Goswami, who has more than two decades of experience in the life sciences industry, was the CFO since early 2023 and will serve as an adviser till June 30, the company said. Prior to Summit, Dhingra was the CFO at medical test maker CareDx. He has also spent about 18 years at equipment maker Agilent Technologies. Illumina has also reaffirmed its forecast for the first quarter and full-year 2024. The company had in February
Hence then, the article about illumina cfo to depart summit therapeutics ankur dhingra named successor was published today ( ) and is available onTimes of San Diego ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details Finally We wish PressBee provided you with enough information of ( Illumina CFO to Depart, Summit Therapeutics’ Ankur Dhingra Named Successor )